Business Name: |
Kishore Kamal MD |
Contact Person: |
Kamal Kishore |
Address: |
3315 North Seminary St, Galesburg, Illinois 61401 |
Phone Number: |
(877) 223-7403 |
Website Address: |
illinoisretinainstitute.com |
Annual Revenue (USD): |
$500.000 to $999.999 |
Location Type: |
Single Location |
Employee Number: |
1 to 4 |
Business Type: |
B2C (Business to Consumer) |
Business Category: |
Doctors |
SIC Code: |
8011 |
NAICS Code: |
6211110 |
Share This Business: |
|
Related Businesses: |
James A Klein MD - Galesburg, IL 61401 Ekong Anthony S MD - Galesburg, IL 61401 Flacco Richard M MD - Galesburg, IL 61401 Cottage Neurosciences - Galesburg, IL 61401 Herman Christopher MD - Galesburg, IL 61401 Padmanabhan P MD - Galesburg, IL 61401 Benejam Ralph MD - Galesburg, IL 61401 Wiechert M A MD - Galesburg, IL 61401 Arora Vijay MD - Galesburg, IL 61401 Attaluri Jayalakshmi MD - Galesburg, IL 61401 Shaffer Richard L DO - Galesburg, IL 61401 Schwab Peter M MD - Galesburg, IL 61401 Soderstrom Carl W MD - Galesburg, IL 61401 Parungao R Sherwin MD - Galesburg, IL 61401 Srini P MD - Galesburg, IL 61401 Klein James A MD - Galesburg, IL 61401 Kesavan B S MD - Galesburg, IL 61401 Stauch Carl E MD - Galesburg, IL 61401 Heyde Raymond R S MD - Galesburg, IL 61401 Flacco Valerie MD - Galesburg, IL 61401 |
The company Kishore Kamal MD provides B2C services in the form of Doctors from its single location in Illinois.
1 to 4 employees work for Kishore Kamal MD, and the business now earns $500.000 to $999.999 per annum.
Kishore Kamal MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Kishore Kamal MD, please call Kamal Kishore with the phone number (877) 223-7403 or visit its single location at 3315 North Seminary St in Galesburg, Illinois 61401.
The location of the single location can also be found using the coordinates 40.98673,-90.36355.
Read more details about this business on the webpage illinoisretinainstitute.com or follow the company’s social media accounts, on Twitter and on Facebook.